Pyott David E I
SEC-identified person · CIK 1051578 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | Director | filed 2026–2026 |
| Alnylam Pharmaceuticals, INC. ALNY | Director | filed 2015–2026 |
| Pliant Therapeutics, INC. PLRX | Director | filed 2021–2025 |
| Biomarin Pharmaceutical INC BMRN | Director | filed 2016–2024 |
| Avery Dennison Corp AVY | Director | filed 2006–2020 |
| Allergan INC AGN | Director · Chairman, President and CEO | filed 2006–2015 |
| Edwards Lifesciences Corp ew | Director | filed 2006–2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.